The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
B | Blood and blood forming organs | |
2
|
B05 | Blood substitutes and perfusion solutions | |
3
|
B05Z | Hemodialytics and hemofiltrates | |
4
|
B05ZB | Hemofiltrates |
| Document | Type | Information Source | |
|---|---|---|---|
| ACCUSOL 35 POTASSIUM Solution for haemofiltration, haemodialysis and haemodiafiltration | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| BIPHOZYL Solution for haemodialysis | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| CIFOBAN Solution for infusion | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| HEMOSOL B0 Solution for haemodialysis / haemofiltration | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| MULTIBIC Solution for haemodialysis/haemofiltration | MPI, EU: SmPC | Marketing Authorisation Holder | |
| PHOXILIUM Solution for haemodialysis / haemofiltration | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| PRISMASOL Renal replacement solution | MPI, US: SPL/PLR | FDA, National Drug Code (US) |